Biomedical Innovation

A researcher, seen through a window, observes a DNA colony development at Bioaster Technology Research Institute in Lyon, October 31, 2014. Bioaster conducts research in microbiology related to infectious diseases. REUTERS/Robert Pratta (FRANCE - Tags: SCIENCE TECHNOLOGY BUSINESS HEALTH)

Blog Post

Gene editing: New challenges, old lessons

March 15, 2016, Walter D. Valdivia

Walter Valdivia discusses the ethics and patent controversies surrounding a new gene editing technique called CRISPR-Cas9. Several conferences of scientists have failed to reach a consensus on the bioethics of CRISPR, and biotechnology companies continue to receive funding based on contested CRISPR patents.

View All Research on Biomedical Innovation ›Show 10 More